HomeNewsNeuroscienceParkinson's

  • Novo Nordisk to focus on Parkinson’s & Diabetes stem cell-based therapies

    • May 18, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • NTCELL for Parkinson’s disease shows promising results on efficacy and safety in Ph II trials

    • May 16, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • First Parkinson’s patient treated with Insightec’s Incisionless Brain Surgery

    • May 12, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Amneal Initiates Phase 3 Study for IPX203 in Advanced Parkinson’s Disease Patients

    • May 8, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • New Technology to help Parkinson’s patients sleep through surgery

    • May 7, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Novel treatments for Parkinson’s to be discovered by e-Therapeutics & C4X collaboratively

    • May 2, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • ACADIA Pharmaceuticals reaffirms Nuplazid’s Benefit/Risk Profile

    • April 28, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • FDA re-examining safety of Nuplazid post reports of spike in adverse event

    • April 27, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Brain Injury increases Parkinson’s risk, claims a latest study

    • April 22, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Anavex to initiate Ph 2 study in Parkinson’s Disease for its drug ANAVEX®2-73

    • April 21, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more